HOME › DRUGS › SUGEMALIMAB
ACTIVE SUBSTANCE / INN

SUGEMALIMAB

Brand name(s): Cejemly
EMA LISTED
AUTHORISED
Carcinoma, Non-Small-Cell Lung
ACTIVE SUBSTANCE
Sugemalimab
REGULATORS
EMA
SPONSORS / MAH
Cstone Pharmaceuticals Ireland Limited
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
CejemlyCstone Pharmaceuticals Ireland LimitedAuthorised24/07/2024Carcinoma, Non-Small-Cell Lung

FULL INTELLIGENCE ON SUGEMALIMAB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →